UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 62 filers reported holding UNIQURE NV in Q3 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $319,000 | -45.4% | 4,446 | -70.1% | 0.02% | -44.8% |
| Q3 2019 | $584,000 | -48.6% | 14,846 | +2.1% | 0.03% | -54.7% |
| Q2 2019 | $1,137,000 | +156.1% | 14,546 | +95.4% | 0.06% | +137.0% |
| Q1 2019 | $444,000 | -15.1% | 7,446 | -59.0% | 0.03% | -20.6% |
| Q4 2018 | $523,000 | -55.0% | 18,156 | -43.2% | 0.03% | -35.8% |
| Q3 2018 | $1,162,000 | +25.2% | 31,957 | +30.1% | 0.05% | +39.5% |
| Q2 2018 | $928,000 | +291.6% | 24,557 | +111.1% | 0.04% | +322.2% |
| Q3 2015 | $237,000 | -46.6% | 11,631 | -36.4% | 0.01% | -40.0% |
| Q1 2015 | $444,000 | – | 18,295 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |